Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-04-01 @ 8:31 PM
Study NCT ID:
NCT06957366
Status:
RECRUITING
Last Update Posted:
2025-05-09
First Post:
2025-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Sponsor:
McMaster University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PAUSE 2 RCT (CTO 4938)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None